Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV [NA]

View source ↗

Summary

A completed clinical trial evaluated the efficacy of Papilocare Gel in repairing cervical lesions caused by human papillomavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Papilocare Gel

Snippet

Sponsor: Procare Health Iberia S.L. | Conditions: HPV Infection, Lesion Cervix | NA | Status: COMPLETED